Instem PLC (AIM:INS) CEO Phil Reason discusses the company's first-half results with Proactive's Stephen Gunnion, saying it delivered a strong performance, bolstered by last year's three acquisitions.
While there are "clearly some real macroeconomic challenges", Reason said life sciences R&D (research and development) is fairly robust at the moment.
"We have been enjoying the strong end-user markets that we play in," he added.
#ProactiveInvestors #Instem #lifesciences #AIM